Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16BOEHRINGER INGELHEIM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BePharma
Not Confirmed

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7579449

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212614

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-01

blank

02

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7579449

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206111

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-01

blank

03

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7579449

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206111

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-01

blank

04

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7579449

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206111

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-01

blank

05

arrow
BePharma
Not Confirmed

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7579449

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212614

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-01

blank

06

arrow
BePharma
Not Confirmed

EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7579449

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212614

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-01

blank

07

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EMPAGLIFLOZIN; LINAGLIPTIN

US Patent Number : 7579449

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206073

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-01

blank

08

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7579449

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 208658

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-01

blank

09

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7579449

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206111

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-01

blank

10

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 7579449

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 208658

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-01

blank